Two Potent OXE-R Antagonists: Assignment of Stereochemistry

Citations Over TimeTop 22% of 2014 papers

Abstract

5-Oxo-6,8,11,14-eicosatetraenoic acid (5-oxo-ETE) is formed by the oxidation of 5-hydroxy-6E,8Z,11Z,14Z-eicosatetraenoic acid (5-HETE), which is a major metabolite of enzymatic oxidation of arachidonic acid (AA). 5-Oxo-ETE is the most potent lipid chemoattractant for human eosinophils. Its actions are mediated by the selective OXE receptor, which is therefore an attractive target in eosinophilic diseases such as allergic rhinitis and asthma. Recently, we have reported two excellent OXE receptor antagonists that have IC50 values at low nanomolar concentrations. Each of these antagonists has a chiral center, and the isolation of the individual enantiomers by chiral high-performance liquid chromatography (HPLC) revealed that in each case one enantiomer is over 300 times more potent than the other. To unambiguously assign the stereochemistry of these enantiomers and to provide access to larger amounts of the active compounds for biological testing, we report here their total synthesis.

Related Papers

• → Effective chiral pool synthesis of both enantiomers of the TRPML inhibitor trans‐ML‐SI3(2021)7 cited
• → Stereoselective pharmacokinetics of ibuprofen in rats: effect of enantiomer-enantiomer interaction in plasma protein binding(1997)22 cited
• → Synthesis and biological activity of enantiomeric pairs of 5-vinylthiolactomycin congeners(2007)15 cited
• → Chirality-dependent DNA reactivity as the possible cause of the differential mutagenicity of the two components in an enantiomeric pair of epoxides(1990)33 cited
• → Separation of racemiccloso-3,3-(η3,2-norbornadienyl)rhodacarboranes into enantiomers by HPLC on chiral stationary phasesinto enantiomers by HPLC on chiral stationary phases(2000)4 cited